Source link : https://newshealth.biz/health-news/next-gen-oral-serd-cuts-recurrence-risk-in-early-breast-cancer/
(MedPage Today) — At the San Antonio Breast Cancer Symposium, investigators reported phase III results showing that the oral selective estrogen-receptor degrader (SERD) giredestrant significantly reduced recurrence risk compared with standard… Source link : https://www.medpagetoday.com/meetingcoverage/sabcs-vp-earlybrca/119132 Author : Publish date : 2025-12-22 17:28:00 Copyright for syndicated content belongs to the linked Source.
The post Next-Gen Oral SERD Cuts Recurrence Risk in Early Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-22 17:28:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8